DOI:
10.1055/s-00034925
Hämostaseologie
LinksClose Window
References
Gisslinger H, Klade C, Georgiev P. et al; PROUD-PV Study Group.
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.
Lancet Haematol 2020;
7 (03) e196-e208
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.